We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CTLT market cap is 10.15B. The company's latest EPS is USD -1.4164 and P/E is -39.73.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.15B | 1.04B | 1.06B | 982M | 1.02B |
| Operating Income | 138M | -235M | -126M | -726M | -112M |
| Net Income | 81M | -227M | -110M | -759M | -206M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.52B | 3.09B | 4B | 4.83B | 4.26B |
| Operating Income | 273.9M | 394.4M | 828M | 755M | -163M |
| Net Income | 137.4M | 173M | 529M | 503M | -256M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.15B | 10.83B | 10.78B | 10.02B | 9.99B |
| Total Liabilities | 6.24B | 6.13B | 6.17B | 6.18B | 6.3B |
| Total Equity | 4.91B | 4.7B | 4.61B | 3.84B | 3.69B |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.18B | 7.78B | 9.11B | 10.51B | 10.78B |
| Total Liabilities | 3.9B | 4.27B | 4.84B | 5.71B | 6.17B |
| Total Equity | 1.68B | 2.9B | 3.92B | 4.8B | 4.61B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 122M | 58M | 254M | -70M | 42M |
| Investing | -724M | -834M | -955M | -84M | -179M |
| Financing | 597M | 572M | 521M | 98M | 84M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 247.7M | 440.3M | 433M | 439M | 254M |
| Investing | -1.51B | -827.5M | -649M | -1.88B | -955M |
| Financing | 1.2B | 1B | 142M | 1.03B | 521M |
| Market Cap | 10.15B |
| Price to Earnings Ratio | -39.73 |
| Price to Sales Ratio | 2.39 |
| Price to Cash Ratio | 36.32 |
| Price to Book Ratio | 2.21 |
| Dividend Yield | - |
| Shares Outstanding | 180.74M |
| Average Volume (1 week) | 2.03M |
| Average Volume (1 Month) | 1.68M |
| 52 Week Change | 12.21% |
| 52 Week High | 60.20 |
| 52 Week Low | 31.45 |
| Spread (Intraday) | 0.02 (0.04%) |
| Company Name | Catalent Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.catalent.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
